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Purpose: This study was conducted to investigate the effect that detection of chron-
ic disease via health screening programs has on health behaviors, particularly smok-
ing. Materials and Methods: We analyzed national health insurance data from 
2007 and 2009. Subjects who were 40 years of age in 2007 and eligible for the life 
cycle-based national health screening program were included. The total study popu-
lation comprised 153518 individuals who participated in the screening program in 
2007 and follow-up screening in 2009. Multiple logistic regression analyses were 
conducted by sex, with adjustment for health insurance type, socioeconomic status, 
body mass index, diabetes, hypertension, hyperlipidemia, and family history of car-
diovascular and/or neurovascular disease. Results: Among men with smoking be-
havior changes, those newly diagnosed with hyperlipidemia were more likely to 
show a positive health behavior change, such as smoking cessation, and were less 
likely to have a negative behavior change (e.g., smoking initiation). Additionally, 
men newly diagnosed with diabetes showed lower rates of negative health behavior 
changes compared to those without disease. Body mass index (BMI)≥25, compared 
to BMI<23, showed higher rates of positive health behavior changes and lower 
rates of negative health behavior changes. Newly diagnosed chronic disease did not 
influence smoking behavior in women. Conclusion: Smoking behavior changes 
were only detected in men who participated in health screening programs. In partic-
ular, those newly diagnosed with hyperlipidemia were more likely to stop smoking 
and less likely to start smoking. 
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INTRODUCTION
The purposes of health screening programs are to decrease mortality and incidence 
rates, as well as increase early detection and treatment rates, for target diseases.1 
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media communications, interpersonal interactions, or remind-
er postcards from health care providers.13 New detection of 
diseases via health screening programs could increase one’s 
perceived susceptibility and severity, and newly diagnosed 
individuals who participate in a physician consultation pro-
gram could gain perceived benefits of guided decisions on 
courses of action. 
The effect of disease detection via health screening pro-
grams on health behavior changes is an important issue in 
health care. Regarding smoking behavior, Hsu, et al. discov-
ered a positive effect on smoking behavior with cancer diag-
nosis.14,15 Also, Neutel, et al.16 reported that newly diagnosed 
hypertensive patients often quit smoking. Accordingly, the 
purpose of this study was to investigate the effect that detec-
tion of chronic disease via health screening programs has on 
health behaviors, particularly smoking.
MATERIALS AND METHODS
Subjects
The baseline age of the study subjects was 40 years in 2007 
and 42 years in 2009. A total of 312480 individuals partici-
pated in the life cycle-based national health screening pro-
gram in 2007, and 194238 of these participants completed 
follow-up screening in 2009. After excluding participants 
who did not participate in one of the screening sessions, as 
well as those for whom data for variables were missing and 
had unclear responses, the final study population was 153518 
(77307 men and 76211 women). 
The subjects were recruited from the NHIC; all were aged 
40 years and were eligible for the life cycle-based national 
health screening program (e.g., covered by NHI or Medical 
aid) in 2007.2 The NHIC and public health centers cam-
paigned (including by mail) to increase the participation rate 
among the target population. Qualified clinics, hospitals, and 
public health centers provided the screening service. Target-
ed individuals were allowed to select a screening center. 
Variables
Independent variables were divided into two groups: demo-
graphic factors [health insurance type (local or corporate), 
socioeconomic status (average monthly income in quartiles, 
and Q4 is the highest income), and body mass index (BMI; 
<23, 23 to <25, and ≥25)] and health status [family history 
of cardiovascular (CV) and/or neurovascular (NV) disease 
(heart disease and stroke; yes/no); status of diabetes, hyper-
Screening is thus considered to be a form of secondary pre-
vention against disease.2 Nevertheless, while screening pro-
grams are commonly offered as part of preventive health 
services in many countries, participation rates play a signif-
icant role in increasing the benefits thereof.3 
In Korea, a nationwide health screening program was initi-
ated in 1980, targeting individuals with chronic diseases 
working for the government or in schools.2 In 1995, the Min-
istry of Health and Welfare initiated the General Health 
Screening Program (GHSP)2 to include local and corporate 
subscribers with National Health Insurance (NHI). In 2007, a 
new life cycle-based national health screening program was 
implemented to overcome the limitations of the GHSP.4 This 
program targeted participants aged 40 and 66 years to cap-
ture health transitions in their life cycle: middle age begins 
around the age of 40 years, at which time the incidence of 
chronic disease increases;5 old age begins around 66 years, at 
which time geriatric approaches to health promotion are need-
ed.6 In contrast to the GHSP, the life cycle-based national 
health screening program provides follow-up consultation 
services after screening to modify participants’ health behav-
iors.1 The National Health Insurance Corporation (NHIC) re-
ported that 69.8% of the participants were satisfied with this 
program, and 65% felt that it was superior to the GHSP.7 
Furthermore, the NHIC stated that participants who com-
pleted primary and secondary screening in 2009 and 2011, 
respectively, were more likely to change their lifestyles 
(41%) than were those who participated only in primary 
screening in 2009 (29%).8
Kasl and Cobb9,10 defined health behaviors as “any activity 
undertaken by a person who believes himself to be healthy 
for the purpose of preventing disease or detecting disease in 
an asymptomatic stage.” To explain health behavior changes, 
social psychologists in the US introduced the health belief 
model in the 1950s to evaluate “the widespread failure of 
people to accept disease preventives or screening tests for 
the early detection of asymptomatic disease.”9,11 Variables 
affecting health behavior, such as demographic, sociopsy-
chological, and structural variables, were identified.12 In ad-
dition to these variables, several dimensions affecting health 
behavior changes were established; these included perceived 
susceptibility, severity, benefits, and barriers.12,13 Rosen-
stock13 stated that the levels of perceived susceptibility and 
severity influence an individual’s actions, and perceived ben-
efits help to determine preferred paths of action. Some form 
of stimulation is needed in the decision-making process: it 
may be internal, such as symptoms, or external, such as mass 
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lation. A total of 153518 individuals (77307 men and 76211 
women; 94193 non-smokers, 20403 ex-smokers, 38922 cur-
rent smokers) participated in screening in 2007. In 2007, 3466 
individuals (1443 non-smokers, 611 ex-smokers, 1412 current 
smokers) were newly diagnosed with diabetes; 9823 (4388 
non-smokers, 1944 ex-smokers, 3491 current smokers) were 
newly diagnosed with hypertension; and 22023 (8863 non-
smokers, 4059 ex-smokers, 9101 current smokers) were new-
ly diagnosed with hyperlipidemia.
Changes in smoking behavior during the study period are 
described in Table 2. Most (97.6%) individuals who were 
non-smokers in 2007 remained ex-smokers or non-smokers 
in 2009; 2.4% were current smokers in 2009. Most (83.8%) 
individuals who were ex-smokers in 2007 retained this sta-
tus, although 16.2% were current smokers in 2009. Similarly, 
most (87.0%) individuals who were current smokers in 2007 
continued to smoke, although 13.0% were ex-smokers or 
non-smokers in 2009.
Table 3 and 4 show the results of the multiple logistic re-
gression analyses of changes in smoking behavior. Table 3 
lists the results of a positive change in smoking behavior 
among current smokers in 2007. The analysis revealed no 
significant relationship among women. In men, the risk of 
smoking cessation was 1.11 [95% confidence interval (CI), 
1.03‒1.20] times higher for men newly diagnosed with hy-
perlipidemia in 2007 than among those who had never had 
hyperlipidemia. Smoking cessation was 1.33 (95% CI, 
1.05‒1.68) times higher for men who had known diabetes in 
2007 than among those who had never had diabetes. The risk 
of smoking cessation was 1.06 (95% CI, 0.95‒1.19) times 
higher for men newly diagnosed with hypertension in 2007 
than among those who had never had hypertension, al-
tension, and hyperlipidemia (none, known, and newly diag-
nosed)]. “No disease” was defined as no history of disease 
and no disease in 2007. “Known disease” was defined as a 
history of disease and diagnosed with disease in 2007. “New-
ly diagnosed with disease” was defined as no history of dis-
ease and a new diagnosis.
Changes in smoking behavior (positive, none, negative) 
was used to characterize the dependent variable (Fig. 1). 
“Positive change” was defined as smoking cessation (smoker 
in 2007, ex-smoker in 2009). “No change” was defined as no 
smoking behavior change between 2007 and 2009. “Negative 
change” was defined as smoking initiation (ex-smoker or non-
smoker in 2007, smoker in 2009). 
Statistical analysis
Multiple logistic regression analyses were conducted adjust-
ing for health insurance type, socioeconomic status, BMI, di-
abetes, hypertension, hyperlipidemia, and family history of 
CV and/or NV disease. This study conducted multiple logis-
tic regression analyses for two groups, current smoker group 
and ex-smoker or non-smoker group in 2007. We analyzed 
the current smoker group for smoking cessation and the ex-
smoker or non-smoker group for smoking initiation. The 
analysis was stratified by sex due to differences in smoking 
characteristics between men and women.17 Statistical analy-
ses were performed using SAS software (version 9.2; SAS 
Institute Inc., Cary, NC, USA).
RESULTS
Table 1 shows the baseline characteristics of the study popu-
2007
Yes 
(current smoker)
n=38922
No
(ex-smoker & non-smoker)
n (ex-smoker)=20403
n (non-smoker)=94193
Smoking status
Diagnosis with chronic disease
‘NO’ 
or
‘KNOWN’
or
‘NEW’
‘NO’ 
or
‘KNOWN’
or
‘NEW’
Diabetes/hypertension/hyperlipidemia
2009
Positive change
(change to ex-smoker)
n=5063
No change
n=142929
Negative change 
(change to smoker)
n=5526
Fig. 1. Flowchart of study design.
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DISCUSSION
In this study, to investigate the relationship between disease 
detection by screening programs and changes in smoking be-
havior, changes among women and men were analyzed with 
adjustment for health insurance type, socioeconomic status, 
BMI, diabetes, hypertension, hyperlipidemia, and family his-
tory of CV and/or NV disease. 
In this study, the probability of smoking cessation among 
current smokers was higher among men with newly diagnosed 
hyperlipidemia and smoking initiation among ex-smoker or 
non-smoker was lower among men with newly diagnosed dia-
betes or hyperlipidemia, compared to those without disease, 
respectively. Meanwhile, studies have mentioned that hyper-
lipidemia patients are more likely to not know of their disease 
before being diagnosed by a doctor, compared to those with 
though the result was not statistically significant. The risk 
of smoking cessation was 1.17 (95% CI, 1.01‒1.35) times 
higher among men with BMI≥25, compared to men with 
BMI<23. Table 4 shows the results of a negative change in 
smoking behavior among ex-smokers or non-smokers in 
2007. Among men, the risk of smoking initiation was 0.75 
(95% CI, 0.64‒0.88) times and 0.79 (95% CI, 0.73‒0.85) 
times lower for those newly diagnosed with diabetes or hy-
perlipidemia in 2007 than among those who had never had 
diabetes or hyperlipidemia, respectively. The risk of smok-
ing initiation was 1.55 (95% CI, 1.31‒1.82) times higher for 
those with known hypertension in 2007 than among those 
who had never had hypertension. The risk of smoking initi-
ation was 0.62 (95% CI, 0.55‒0.69) times lower among 
men with BMI≥25, compared to men with BMI<23. There 
were no significant results in women.
Table 1. Characteristics of Subjects at Baseline (2007)
Variables Total, n (%) Non-smoker, n (%) Ex-smoker, n (%) Current smoker, n (%) p value
Total 153518 (100.0) 94193 (61.4) 20403 (13.3) 38922 (25.4)
Sex <0.0001
Men 77307 (50.4) 20116 (26.0) 19691 (25.5) 37500 (48.5)
Women 76211 (49.6) 74077 (97.2) 712 (0.9) 1422 (1.9)
Health insurance type
Local 33871 (22.1) 24440 (72.2) 3242 (9.6) 6189 (18.3)
Corporate 119647 (77.9) 69753 (58.3) 17161 (14.3) 32733 (27.4)
Socioeconomic status <0.0001
Q1 38364 (25.0) 27949 (72.9) 3054 (8.0) 7361 (19.2)
Q2 38393 (25.0) 22086 (57.5) 4961 (12.9) 11346 (29.6)
Q3 38370 (25.0) 21187 (55.2) 6124 (16.0) 11059 (28.8)
Q4 38391 (25.0) 22971 (59.8) 6264 (16.3) 9156 (23.9)
Body mass index <0.0001
<23 107808 (70.2) 72433 (67.2) 11589 (10.8) 23786 (22.1)
23≤ and <25 39489 (25.7) 18938 (48.0) 7502 (19.0) 13049 (33.0)
25≤ 6221 (4.1) 2822 (45.4) 1312 (21.1) 2087 (33.6)
Diabetes <0.0001
No diabetes 147504 (96.1) 91478 (62.0) 19361 (13.1) 36665 (24.9)
Known diabetes 2548 (1.7) 1272 (49.9) 431 (16.9) 845 (33.2)
Newly diagnosed 3466 (2.3) 1443 (41.6) 611 (17.6) 1412 (40.7)
Hypertension <0.0001
No hypertension 138067 (89.9) 87044 (63.0) 17277 (12.5) 33746 (24.4)
Known hypertension 5628 (3.7) 2761 (49.1) 1182 (21.0) 1685 (29.9)
Newly diagnosed 9823 (6.4) 4388 (44.7) 1944 (19.8) 3491 (35.5)
Hyperlipidemia <0.0001
No hyperlipidemia 128088 (83.4) 84022 (65.6) 15526 (12.1) 28540 (22.3)
Known hyperlipidemia 3407 (2.2) 1308 (38.4) 818 (24.0) 1281 (37.6)
Newly diagnosed 22023 (14.4) 8863 (40.2) 4059 (18.4) 9101 (41.3)
Family history of cardiovascular/neurovascular disease <0.0001
No 130643 (85.1) 80121 (61.3) 17145 (13.1) 33377 (25.6)
Yes 22875 (14.9) 14072 (61.5) 3258 (14.2) 5545 (24.2)
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pertension. Among 153518 individuals, 22023 (14.4%) were 
newly diagnosed with hyperlipidemia, while only 3466 
(2.3%) and 9823 (6.4%) were newly diagnosed with diabetes 
diabetes or hypertension.18,19 In the present study, the number 
of people who were newly diagnosed with hyperlipidemia 
was greater than those newly diagnosed with diabetes or hy-
Table 3. Risk of Positive Change in Smoking Behavior for Current Smokers in 2007*
Variable
Men
p for trend
Women
p for trend
OR 95% CI OR 95% CI
Health insurance type
Local 1.00
0.950
1.00
0.019
Corporate 1.00 0.92‒1.09 0.72 0.55‒0.95
Socioeconomic status
Q1 1.00
0.389
1.00
0.320
Q2 1.00 0.91‒1.11 1.24 0.88‒1.74
Q3 0.83 0.75‒0.91 0.92 0.62‒1.37
Q4 0.71 0.64‒0.78 0.85 0.57‒1.27
Body mass index
<23 1.00
0.906
1.00
0.68123≤ and <25 0.93 0.87‒0.99 1.07 0.72‒1.58
25≤ 1.17 1.01‒1.35 1.13 0.49‒2.63
Diabetes
No diabetes 1.00
0.114
1.00
0.554Known diabetes 1.33 1.05‒1.68 0.97 0.38‒2.47
Newly diagnosed 1.08 0.91‒1.27 1.77 0.40‒7.93
Hypertension
No hypertension 1.00
0.288
1.00
0.303Known hypertension 1.01 0.86‒1.18 1.84 0.73‒4.64
Newly diagnosed 1.06 0.95‒1.19 0.56 0.29‒1.09
Hyperlipidemia
No hyperlipidemia 1.00
1.091
1.00
0.253Known hyperlipidemia 0.96 0.81‒1.14 0.52 0.15‒1.75
Newly diagnosed 1.11 1.03‒1.20 1.40 0.84‒2.33
Family history of cardiovascular/neurovascular disease
No 1.00
0.556
1.00
0.243
Yes 0.97 0.89‒1.06 0.82 0.59‒1.14
OR, odds ratio; CI, confidence interval.
*Positive change: change to ex-smoker in 2009 among current smokers in 2007.
Table 2. Changes in Smoking Behavior during the Study Period
Category
2007 2009
n=153518 (%)
No (non-smoker & ex-smoker) Yes (current smoker)
n=77307 (%) n=76211 (%)
Non-smoker
Total 94193 (100.0) 91964 (97.6) 2229 (2.4)
Men 20116 (21.4) 18207 (90.5) 1909 (9.5)
Women 74077 (78.6) 73757 (99.6) 320 (0.4)
Ex-smoker
Total 20403 (100.0) 17106 (83.8) 3297 (16.2)
Men 19691 (96.5) 16550 (84.1) 3141 (16.0)
Women 712 (3.5) 556 (78.1) 156 (21.9)
Current smoker
Total 38922 (100.0) 5063 (13.0) 33859 (87.0)
Men 37500 (96.3) 4802 (12.8) 32698 (87.2)
Women 1422 (3.7) 261 (18.4) 1161 (81.7)
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27.5% and 17.5%, respectively, in 2011.22 According to the 
OECD Factbook 2011‒2012: Economic, Environmental and 
Social Statistics, the difference in smoking rates between men 
and women was larger in Korea than in other OECD coun-
try.22 The sex-based difference in smoking behavior for Ko-
rea is related to many variables, including gender roles, so-
cial norms,17 and other cultural and economic factors.23 For 
instance, marriage status affects this difference in Asian, but 
not European, countries.1,17 In addition, cigarette use is ac-
ceptable under cultural norms for men in social and business 
settings.24 However, in women, smoking is considered to be 
against cultural norms.24 Previously, according to a trans-
theoretical model, Audrain, et al.25 noted gender differences 
in smoking behavior changes: gender differences were dis-
covered for several stages of smoking behavior change, such 
as ready to quit smoking, perceived benefits and cost of 
smoking, and self-efficacy. For these reasons, our analysis 
of changes in smoking behavior was stratified by sex.
and hypertension, respectively. According to Omboni, et al.,19 
awareness of the presence of CV risk factors among individ-
uals newly diagnosed with hypertension, diabetes, or hyper-
lipidemia differs significantly: in their study, 44.5% of peo-
ple diagnosed with hyperlipidemia, 22.7% with hypertension, 
and 3.5% with diabetes were not aware of their condition. 
Therefore, differences in a lack of awareness of existing dis-
ease may influence rates of change in smoking behaviors for 
individual conditions. Additionally, according to BMI, the 
risk of smoking initiation was lower and the risk of cessa-
tion was higher among men with a BMI≥25, compared to 
those with BMI<23, similar to results reported by Lee, et al.;20 
in their study, among individuals who successfully quit smok-
ing, 72.4% had a BMI≥23.
In 2010, smoking rates among men and women in Korea 
were 48.3% and 6.3%, respectively.21 According to the Organi-
zation for Economic Co-operation and Development (OECD), 
the average smoking rates among men and women were 
Table 4. Risk of Negative Change in Smoking Behavior for Ex- or Non-Smokers in 2007*
Variable
Men
p for trend
Women
p for trend
OR 95% CI OR 95% CI
Health insurance type
Local 1.00
<0.0001
1.00
<0.0001
Corporate 0.85 0.78‒0.93 3.16 2.63‒3.80
Socioeconomic status
Q1 1.00
0.030
1.00
<0.0001
Q2 1.02 0.93‒1.12 1.12 0.89‒1.39
Q3 1.26 1.15‒1.38 1.64 1.26‒2.13
Q4 1.06 0.97‒1.16 2.81 2.10‒3.75
Body mass index
<23 1.00
<0.0001
1.00
0.96023≤ and <25 0.98 0.92‒1.05 0.98 0.77‒1.25
25≤ 0.62 0.55‒0.69 1.02 0.58‒1.80
Diabetes
No diabetes 1.00
<0.0001
1.00
0.954Known diabetes 1.04 0.83‒1.31 0.64 0.32‒1.26
Newly diagnosed 0.75 0.64‒0.88 0.70 0.36‒1.37
Hypertension
No hypertension 1.00
0.094
1.00
0.683Known hypertension 1.55 1.31‒1.82 1.00 0.56‒1.76
Newly diagnosed 1.02 0.92‒1.13 0.90 0.57‒1.43
Hyperlipidemia
No hyperlipidemia 1.00
<0.0001
1.00
0.099Known hyperlipidemia 1.20 0.99‒1.46 2.71 0.66‒11.08
Newly diagnosed 0.79 0.73‒0.85 0.74 0.55‒1.01
Family history of cardiovascular/neurovascular disease
No 1.00
<0.0001
1.00
0.070
Yes 1.32 1.21‒1.45 1.29 0.98‒1.69
OR, odds ratio; CI, confidence interval.
*Negative change: change to current smoker in 2009 among ex-smokers or non-smokers in 2007.
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Screening Program for Transitional Ages. Seoul: National Health 
Insurance Corporation; 2008. 
8. The analysis of effectiveness of National Screening Program for 
Transitional Ages in 2007. Seoul: National Health Insurance Cor-
poration; 2010. 
9. Rosenstock IM. The health belief model and preventive health be-
havior. Health Educ Behav 1974;2:354-86.
10. Kasl SV, Cobb S. Health behavior, illness behavior, and sick role 
behavior. I. Health and illness behavior. Arch Environ Health 
1966;12:246-66.
11. Janz NK, Becker MH. The Health Belief Model: a decade later. 
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12. DiClemente RJ, Peterson JL. Preventing AIDS: theories and 
methods of behavioral interventions. 2nd ed. New York: Springer; 
1994.
13. Rosenstock IM. Historical origins of the health belief model. 
Health Educ Behav 1974;2:328-35.
14. Park JJ, Park HA. Prevalence of cigarette smoking among adult 
cancer survivors in Korea. Yonsei Med J 2015;56:556-62. 
15. Hsu CC, Kwan GN, Chawla A, Mitina N, Christie D. Smoking 
habits of radiotherapy patients: did the diagnosis of cancer make 
an impact and is there an opportunity to intervene? J Med Imaging 
Radiat Oncol 2011;55:526-31. 
16. Neutel CI, Campbell N; Canadian Hypertension Society. Changes 
in lifestyle after hypertension diagnosis in Canada. Can J Cardiol 
2008;24:199-204.
17. Cho HJ, Khang YH, Jun HJ, Kawachi I. Marital status and smok-
ing in Korea: the influence of gender and age. Soc Sci Med 2008; 
66:609-19. 
18. Gnasso A, Calindro MC, Carallo C, De Novara G, Ferraro M, 
Gorgone G, et al. Awareness, treatment and control of hyperlipi-
daemia, hypertension and diabetes mellitus in a selected popula-
tion of southern Italy. Eur J Epidemiol 1997;13:421-8.
19. Omboni S, Carabelli G, Ghirardi E, Carugo S. Awareness, treat-
ment, and control of major cardiovascular risk factors in a small-
scale Italian community: results of a screening campaign. Vasc 
Health Risk Manag 2013;9:177-85.
20. Lee KJ, Chang CJ, Kim MS, Lee MH, Cho YH. [Factors associat-
ed with success of smoking cessation during 6 months]. Taehan 
Kanho Hakhoe Chi 2006;36:742-50.
21. Korea Centers for Disease Control and Prevention. Korea Nation-
al Health and Nutrition Examination Survey (KNHANES) 2010. 
[accessed on 2013 October 10]. Available at: http://knhanes.cdc.
go.kr/knhanes/index.do. 
22. Organisation for Economic Co-operation and Development 
(OECD), OECD Factbook 2011-2012: Economic, Environmental 
and Social Statistics 2012. [accessed on 2013 October 10]. Avail-
able at: http://www.oecd.org/. 
23. Hitchman SC, Fong GT. Gender empowerment and female-to-
male smoking prevalence ratios. Bull World Health Organ 2011; 
89:195-202. 
24. French DJ, Jang SN, Tait RJ, Anstey KJ. Cross-national gender 
differences in the socioeconomic factors associated with smoking 
in Australia, the United States of America and South Korea. Int J 
Public Health 2013;58:345-53. 
25. Audrain J, Gomez-Caminero A, Robertson AR, Boyd R, Orleans 
CT, Lerman C. Gender and ethnic differences in readiness to 
change smoking behavior. Womens Health 1997;3:139-50.
This study has several limitations. A lot of data were miss-
ing from responses, which may have impacted the statisti-
cal power of the analysis. In addition, the multiple logistic re-
gression analysis did not allow for the determination of causal 
relationships. Furthermore, we had no information about the 
number of cigarettes smoked, smoking duration, or experi-
ences with smoking cessation attempts. Despite these limita-
tions, this study is the first to focus on behavioral changes in-
duced by the life cycle-based national health screening program 
in Korea. Future studies should be conducted using advanced 
statistical methods and data obtained with high response 
rates, as well as adjustment for additional smoking-related 
variables.
In conclusion, smoking behavior changes after participa-
tion in a health screening program were detected only in Ko-
rean men. In particular, among men newly diagnosed with 
hyperlipidemia, current smokers were more likely to stop 
smoking, while non-smokers or ex-smokers were less likely 
to start smoking.
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